|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號(hào)：A101005 |
| 產(chǎn)品名稱：A 131701 |
| 產(chǎn)品CAS：181490-18-6 |
| 規(guī)格含量：2.5mg |
| 產(chǎn)品價(jià)格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細(xì)介紹 |
| 標(biāo)準(zhǔn)品編號(hào): |
A101005 |
| 名稱: |
A 131701 |
| 別名: |
3-[2-[(3aR,9bR)-1,3,3a,4,5,9b-Hexahydro-6-methoxy-2H-benz[e]isoindol-2-yl]ethyl]pyrido[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione; 3-(2-((3aR,9bR)-6-Methoxy-3,3a,4,5-tetrahydro-1H-benzo[e]isoindol-2(9bH)-yl)ethyl)pyrido[2',3':4,5]thieno[3,2-d]pyrimidine-2,4(1H,3H)-dione; |
| CAS號(hào): |
181490-18-6 |
| 分子式: |
C??H??N?O?S |
| 分子量: |
448.54 |
| 類(lèi)別: |
Research Tools; Molecular Biology; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應(yīng)用: |
A 131701 is a selective α1VIP(LA)adrenoceptor antagonist with potentials for the treatment of benign prostatic hyperplasia. |
| 參考: |
|
|
|
|
?您的位置：
